| 000 | 01301 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513065444.0 | ||
| 264 | 0 | _c19931210 | |
| 008 | 199312s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamauchi, A | |
| 245 | 0 | 0 |
_aRequirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cNov 1993 |
||
| 300 |
_a5535-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCystine _xpharmacology |
| 650 | 0 | 4 |
_aGlutathione _xpharmacology |
| 650 | 0 | 4 | _aGranzymes |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _xdrug effects |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xmetabolism |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xpharmacology |
| 700 | 1 | _aBloom, E T | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 151 _gno. 10 _gp. 5535-44 |
|
| 999 |
_c8227527 _d8227527 |
||